Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial-Reference-Cited by-同舟云学术

Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial

Published:2018-04-16 Issue:1 Volume:18 Page:
ISSN:1472-6963
Container-title:BMC Health Services Research
language:en
Short-container-title:BMC Health Serv Res

Author:

Kerrigan Deanna,Tudor Carrie,Motlhaoleng Katlego,Lebina Limakatso,Qomfu Cokiswa,Variava Ebrahim,Chon Sandy,Martinson Neil,Golub Jonathan E.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s12913-018-3088-8.pdf

Reference14 articles.

1. World Health Organization (WHO). Global tuberculosis report; 2017. http://apps.who.int/iris/bitstream/handle/10665/259366/9789241565516-eng.pdf?sequence=1 . Accessed 11 Oct 2017.

2. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010:CD000171. https://doi.org/10.1002/14651858.CD000171.pub3 .

3. World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. 2011. http://whqlibdoc.who.int/publications/2011/9789241500708_eng.pdf . Accessed 11 Apr 2017.

4. Department of Health, Republic of South Africa. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. 2015. https://www.scribd.com/doc/268965647/National-Consolidated-Guidelines-for-PMTCT-and-the-Management-of-HIV-in-Children-Adolescents-and-Adults . Accessed 11 Apr 2017.

5. Centers for Disease Control and Prevention (CDC). Latent tuberculosis infection: a guide for primary health care providers. 2016. http://www.cdc.gov/tb/publications/ltbi/ . Accessed 11 Apr 2017.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cluster Randomized Trial;Clinical Infectious Diseases;2024-07-22

2. A synthesis of qualitative evidence of barriers and facilitators in implementing guidelines for TB testing in healthcare settings;Implementation Science Communications;2024-03-27

3. End-user perspectives on the acceptability, feasibility, and health equity impacts of Mycobacterium tuberculosis specific antigen-based skin tests compared to interferon gamma release assays and the tuberculin skin test: A semi-structured interview study;2024-03-25

4. Priorities among HIV-positive individuals for tuberculosis preventive therapies;The International Journal of Tuberculosis and Lung Disease;2020-04-01

5. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment;AIDS and Behavior;2018-11-10